Allied Minds

Allied Minds, GE Ventures partner on technology

Thursday, September 29, 2016

Allied Minds and GE Ventures have announced the launch of a strategic alliance to jointly identify and commercialize next-generation technologies. Under the terms of the agreement, Allied Minds and GE Ventures agree to invest in new and existing technologies sourced from both Allied Minds’ and GE’s innovation pipelines.

[Read More]

Allied Minds launches Novare Pharmaceuticals

Wednesday, October 8, 2014

Allied Minds, a Boston, Mass.-based science and technology development and commercialization company, has launched Novare Pharmaceuticals, a biotechnology company focused on developing therapeutic products that help the body replenish and rebuild itself using its own tissue through the modulation of Receptor for Hyaluronan Mediated Motility (RHAMM). Modulation of RHAMM also is of benefit in inflammatory diseases such as bronchopulmonary dysplasia (BPD).

[Read More]